Application 208910
- Type
- NDA
- Sponsor
- RXMTM THERAPS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FIRVANQ KIT | VANCOMYCIN HYDROCHLORIDE | FOR SOLUTION;ORAL | EQ 25MG BASE/ML | Yes | Yes |
| 002 | FIRVANQ KIT | VANCOMYCIN HYDROCHLORIDE | FOR SOLUTION;ORAL | EQ 50MG BASE/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N208910-001 | FIRVANQ KIT | VANCOMYCIN HYDROCHLORIDE | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AA | RLD, RS | 2018-01-26 |
| N208910-002 | FIRVANQ KIT | VANCOMYCIN HYDROCHLORIDE | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AA | RLD, RS | 2018-01-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N208910-001 | AA |
| N208910-002 | AA |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N208910-001 | 10493028 | 2035-03-13 | Drug product | 2019-12-05 | |
| N208910-001 | 10688046 | 2035-03-13 | Drug product | 2020-07-10 | |
| N208910-001 | 10959946 | 2035-03-13 | Drug product | 2021-04-15 | |
| N208910-001 | 10959947 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 |
| N208910-001 | 10959947 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 |
| N208910-001 | 10959948 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 |
| N208910-001 | 10959948 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 |
| N208910-001 | 10959949 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 |
| N208910-001 | 10959949 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 |
| N208910-001 | 11638692 | 2035-03-13 | Drug product | 2023-05-02 | |
| N208910-002 | 10493028 | 2035-03-13 | Drug product | 2019-12-05 | |
| N208910-002 | 10688046 | 2035-03-13 | Drug product | 2020-07-10 | |
| N208910-002 | 10959946 | 2035-03-13 | Drug product | 2021-04-15 | |
| N208910-002 | 10959947 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 |
| N208910-002 | 10959947 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 |
| N208910-002 | 10959948 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 |
| N208910-002 | 10959948 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 |
| N208910-002 | 10959949 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 |
| N208910-002 | 10959949 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 |
| N208910-002 | 11638692 | 2035-03-13 | Drug product | 2023-05-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | AB | RLD, RS | 2018-01-26 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N208910-001 | FIRVANQ KIT | EQ 25MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N208910-002 | FIRVANQ KIT | EQ 50MG BASE/ML | FOR SOLUTION / ORAL | RLD, RS | 2018-01-26 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N208910-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N208910-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208910-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N208910-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208910-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N208910-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208910-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N208910-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208910-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N208910-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208910-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N208910-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208910-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N208910-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N208910-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N208910-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208910-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N208910-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208910-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N208910-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208910-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N208910-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N208910-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N208910-002 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N208910-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N208910-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | N208910-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | N208910-002 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | N208910-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N208910-002 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N208910-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N208910-002 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N208910-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N208910-002 | AB | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N208910-001 | AB | 1 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N208910-002 | AB | 1 | a67488948f0b… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10493028 | 2035-03-13 | Drug product | 2019-12-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10688046 | 2035-03-13 | Drug product | 2020-07-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10959946 | 2035-03-13 | Drug product | 2021-04-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10959947 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10959947 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10959948 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10959948 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10959949 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 10959949 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-001 | 11638692 | 2035-03-13 | Drug product | 2023-05-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10493028 | 2035-03-13 | Drug product | 2019-12-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10688046 | 2035-03-13 | Drug product | 2020-07-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10959946 | 2035-03-13 | Drug product | 2021-04-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10959947 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10959947 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10959948 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10959948 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10959949 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 10959949 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N208910-002 | 11638692 | 2035-03-13 | Drug product | 2023-05-02 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10493028 | 2035-03-13 | Drug product | 2019-12-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10688046 | 2035-03-13 | Drug product | 2020-07-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10959946 | 2035-03-13 | Drug product | 2021-04-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10959947 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10959947 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10959948 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10959948 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10959949 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 10959949 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-001 | 11638692 | 2035-03-13 | Drug product | 2023-05-02 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10493028 | 2035-03-13 | Drug product | 2019-12-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10688046 | 2035-03-13 | Drug product | 2020-07-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10959946 | 2035-03-13 | Drug product | 2021-04-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10959947 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10959947 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10959948 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10959948 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10959949 | 2035-03-13 | U-3105 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 10959949 | 2035-03-13 | U-3104 | Drug product | 2021-04-15 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N208910-002 | 11638692 | 2035-03-13 | Drug product | 2023-05-02 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FIRVANQ | VANCOMYCIN HYDROCHLORIDE | Azurity Pharmaceuticals, Inc | 5aca5508-b577-446c-9980-ab4c7582b4b9 | 2026-07-14 | Warnings, Adverse reactions | 208910 NDA208910 65628-208 65628-204 65628-206 65628-205 |
| Vancomycin Hydrochloride for Oral Solution | VANCOMYCIN HYDROCHLORIDE | Wilshire Pharmaceuticals, Inc. | 4c3d2e99-5351-4442-916a-d2001b0a5f5a | 2026-07-14 | Warnings, Adverse reactions | 208910 NDA208910 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65628-015 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-015 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-015 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-015 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-016 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-016 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-016 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-016 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-204 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-204 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-204 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-204 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-204 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-205 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-205 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-205 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-205 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-205 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-206 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-206 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-206 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-206 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-206 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-208 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-208 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-208 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |
| 65628-208 | FIRVANQ | Vancomycin hydrochloride | CutisPharma, Inc. | NDA | Current |
| 65628-208 | FIRVANQ | vancomycin hydrochloride | Azurity Pharmaceuticals, Inc | NDA | Current |